1598-IL) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepatocellular carcinoma cell line in a dose-dependent manner (orange line). Inhibition of EMCV activity elicited by Recombinant Human IL-29/IFN-lambda 1 (40 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anri-Human IL-29/IFN-lambda 1 Monoclonal Antibody (Catalog # MAB15981). The ND50 is typically 1-4 µg/mL." alt="Recombinant Human IL-29/IFN-lambda 1 (Catalog # 1598-IL) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepatocellular carcinoma cell line in a dose-dependent manner (orange line). Inhibition of EMCV activity elicited by Recombinant Human IL-29/IFN-lambda 1 (40 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anri-Human IL-29/IFN-lambda 1 Monoclonal Antibody (Catalog # MAB15981). The ND50 is typically 1-4 µg/mL." class="big_thumb" />
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB15981-SP | |||
| Carrier Free | MAB15981-500 | |||
1598-IL) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepato-cellular carcinoma cell line in a dose-dependent manner (orange line), as measured by crystal violet staining. Inhibition of EMCV activity elicited by Recombinant Human IL-29/IFN-lambda 1 (40 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL-29/IFN-lambda 1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1598). The ND50 is typically 0.2-1.0 µg/mL." alt="Recombinant Human IL-29/ IFN-lambda 1 (Catalog # 1598-IL) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepato-cellular carcinoma cell line in a dose-dependent manner (orange line), as measured by crystal violet staining. Inhibition of EMCV activity elicited by Recombinant Human IL-29/IFN-lambda 1 (40 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL-29/IFN-lambda 1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1598). The ND50 is typically 0.2-1.0 µg/mL." class="big_thumb" />
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1598-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99978-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90092-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18106-500ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18107-500ul | |||
1598-IL) was serially diluted and captured by Mouse Anti-Human IL‑29/IFN‑ lambda 1 Monoclonal Antibody (Catalog # MAB15981) coated on a Clear Polystyrene Microplate (Catalog # 
1598-IL) was serially diluted and captured by Mouse Anti-Human IL‑29/IFN‑ lambda 1 Monoclonal Antibody (Catalog # ![Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C5) [NBP3-41964] - DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 30ug/ml NBP3-41964; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41964_mouse-il-29-ifn-lambda-1-mab-c5-612202421283870.jpg "Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C5) [NBP3-41964] - DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 30ug/ml NBP3-41964; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C5) [NBP3-41964] - DAB staining on IHC-P; Sample: Human Stomach Tissue; Primary Ab: 30ug/ml NBP3-41964; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41964_mouse-il-29-ifn-lambda-1-mab-c5-61220242151863.jpg)
![Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C11) [NBP3-41961] - DAB staining on IHC-P; Sample: Human Stomach Tissue; Primary Ab: 40ug/ml NBP3-41961; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41961_mouse-il-29-ifn-lambda-1-mab-c11-612202421262992.jpg "Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C11) [NBP3-41961] - DAB staining on IHC-P; Sample: Human Stomach Tissue; Primary Ab: 40ug/ml NBP3-41961; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C11) [NBP3-41961] - DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 40ug/ml NBP3-41961; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41961_mouse-il-29-ifn-lambda-1-mab-c11-612202421283875.jpg)
![Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C4) [NBP3-41963] - DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 30ug/ml NBP3-41963; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41963_mouse-il-29-ifn-lambda-1-mab-c4-612202421121322.jpg "Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C4) [NBP3-41963] - DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 30ug/ml NBP3-41963; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C1) [NBP3-41962] - DAB staining on IHC-P; Sample: Human Stomach Tissue; Primary Ab: 30ug/ml NBP3-41962; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41962_mouse-il-29-ifn-lambda-1-mab-c1-612202421351240.jpg "Immunohistochemistry-Paraffin: IL-29/IFN-lambda 1 Antibody (C1) [NBP3-41962] - DAB staining on IHC-P; Sample: Human Stomach Tissue; Primary Ab: 30ug/ml NBP3-41962; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Western Blot: IL-29/IFN-lambda 1 Antibody [NBP1-77893] - Shows detection of recombinant human IL-29 raised in E.coli. Recombinant protein (0.1 ug, 19.9 kDa) was loaded onto and resolved by SDS-PAGE, then transferred to nitrocellulose. The membrane was blocked with 1% BSA in TBST for 30 min at RT, followed by incubation with Anti-Human IL-29. After washing, membrane was probed with secondary antibody DyLight (TM) 649 conjugated Anti-Rabbit IgG (H&L) (Goat) Antibody diluted 1:20,000 in blocking buffer for 30 min. at RT.](http://images.novusbio.com/fullsize/IL-29-IFN-lambda-1-Antibody-Western-Blot-NBP1-77893-img0001.jpg "Western Blot: IL-29/IFN-lambda 1 Antibody [NBP1-77893] - Shows detection of recombinant human IL-29 raised in E.coli. Recombinant protein (0.1 ug, 19.9 kDa) was loaded onto and resolved by SDS-PAGE, then transferred to nitrocellulose. The membrane was blocked with 1% BSA in TBST for 30 min at RT, followed by incubation with Anti-Human IL-29. After washing, membrane was probed with secondary antibody DyLight (TM) 649 conjugated Anti-Rabbit IgG (H&L) (Goat) Antibody diluted 1:20,000 in blocking buffer for 30 min. at RT.")
